Stephen Tomlinson to Lupus Erythematosus, Systemic
This is a "connection" page, showing publications Stephen Tomlinson has written about Lupus Erythematosus, Systemic.
Connection Strength
0.431
-
The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Arthritis Rheum. 2011 Apr; 63(4):1076-85.
Score: 0.240
-
Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J Immunol. 2008 Jan 15; 180(2):1231-8.
Score: 0.192